How does the first CRISPR treatment work? Can biotech rebound? And when is $300 million not $300 million? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation Program, which will allow innovators to have an easier path to market.

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk about the much-awaited CRISPR-based drug Casgevy, discuss ...

CRISPR Therapeutics: 2025 TIME100 Most Influential CompaniesCRISPR Therapeutics is a biotech company that borrows its name from the groundbreaking gene editing technology CRISPR. As of last year ...

Researchers demonstrate the active role methyl groups play in silencing genes, demonstrating the therapeutic potential of ...

CRISPR-based therapeutics present market opportunities in infectious diseases through genome disruption, host gene editing, and immune cell engineering. Key areas include innovative products, emerging ...

CRISPR-based diagnostics offer transformative solutions for disease detection, utilizing advanced gene-editing tools for precise and rapid molecular testing.

How can we grow enough food without destroying our planet in the process? Physical chemist Brad Ringeisen believes CRISPR may hold the key—by helping to develop climate-resilient crops.